Latest / Decera Clinical Education Oncology Podcast
CELMoDs on the Horizon: A New Chapter in Lymphoma Care
Treatment options for patients with lymphoma are rapidly evolving. In this podcast episode, Alex F. Herrera, MD, and Marc Hoffmann, MD, discuss cereblon E3 ligase modulators (CELMoDs) as potential treatment options for patients with aggressive diffuse large B-cell lymphoma and follicular lymphoma, with a focus on golcadomide, an investigational, oral, first-in-class CELMoD therapy. Topic areas covered include:
Biologic and clinical rationale for the use of CELMoD therapy in lymphoma patients
Emerging clinical trial data on golcadomide alone and in combination with other regimens
Real-world…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.